Standard

Анализ показателей выживаемости и оценка факторов прогноза у больных с метастазами рака почки в легкие. / Карлова, Наталия Александровна; Орлова, Рашида Вахидовна; широкорад, в.и.; Семенов, Дмитрий Владимирович; Кострицкий, С.В.

в: СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ, Том 23, № 2, 12.05.2024, стр. 37-46.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Карлова, НА, Орлова, РВ, широкорад, ВИ, Семенов, ДВ & Кострицкий, СВ 2024, 'Анализ показателей выживаемости и оценка факторов прогноза у больных с метастазами рака почки в легкие', СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ, Том. 23, № 2, стр. 37-46. https://doi.org/10.21294/1814-4861-2024-23-2-37-46

APA

Карлова, Н. А., Орлова, Р. В., широкорад, В. И., Семенов, Д. В., & Кострицкий, С. В. (2024). Анализ показателей выживаемости и оценка факторов прогноза у больных с метастазами рака почки в легкие. СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ, 23(2), 37-46. https://doi.org/10.21294/1814-4861-2024-23-2-37-46

Vancouver

Карлова НА, Орлова РВ, широкорад ВИ, Семенов ДВ, Кострицкий СВ. Анализ показателей выживаемости и оценка факторов прогноза у больных с метастазами рака почки в легкие. СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ. 2024 Май 12;23(2):37-46. https://doi.org/10.21294/1814-4861-2024-23-2-37-46

Author

Карлова, Наталия Александровна ; Орлова, Рашида Вахидовна ; широкорад, в.и. ; Семенов, Дмитрий Владимирович ; Кострицкий, С.В. / Анализ показателей выживаемости и оценка факторов прогноза у больных с метастазами рака почки в легкие. в: СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ. 2024 ; Том 23, № 2. стр. 37-46.

BibTeX

@article{2f6dd146129b46ba86314b277bff6521,
title = "Анализ показателей выживаемости и оценка факторов прогноза у больных с метастазами рака почки в легкие",
abstract = " In patients with lung metastases from renal cell cancer (RCC), it is necessary to search for new prognostic factors influencing survival rates. Aim : To analyze survival rates and identify prognostic factors in patients with lung metastases from RCC. Material and methods . We retrospectively analyzed the data from 655 patients with lung metastases from RCC, who were treated at Moscow city oncology Hospital No. 62 (Moscow) and city clinical oncology center (Saint Petersburg) from 2006 to 2022. Of these patients, 241 (36.8 %) were classified into the intermediate prognosis group, and 278 (42.2 %) into the unfavorable prognosis group. The study investigated clinical and morphologic prognostic factors influencing survival rates in patients with lung metastases from RCC. Statistical analysis was performed using Statistica 10.0 software packages (StatSoft, USA) by constructing Kaplan-Meier curves and survival tables, building a mathematical model of survival. Results . The 3- and 5-year OS rates in patients with lung metastases from RCC (N=655) were 48 % [95 % ci 45–53 %] and 27 % [95 % ci 23–31 %], respectively, with a median OS of 34.9 months [95 % ci 30.4–37.4]. in univariate analysis, ECOG status (p",
author = "Карлова, {Наталия Александровна} and Орлова, {Рашида Вахидовна} and в.и. широкорад and Семенов, {Дмитрий Владимирович} and С.В. Кострицкий",
year = "2024",
month = may,
day = "12",
doi = "10.21294/1814-4861-2024-23-2-37-46",
language = "русский",
volume = "23",
pages = "37--46",
journal = "СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ",
issn = "1814-4861",
publisher = "Томский национальный исследовательский медицинский центр Российской академии наук",
number = "2",

}

RIS

TY - JOUR

T1 - Анализ показателей выживаемости и оценка факторов прогноза у больных с метастазами рака почки в легкие

AU - Карлова, Наталия Александровна

AU - Орлова, Рашида Вахидовна

AU - широкорад, в.и.

AU - Семенов, Дмитрий Владимирович

AU - Кострицкий, С.В.

PY - 2024/5/12

Y1 - 2024/5/12

N2 - In patients with lung metastases from renal cell cancer (RCC), it is necessary to search for new prognostic factors influencing survival rates. Aim : To analyze survival rates and identify prognostic factors in patients with lung metastases from RCC. Material and methods . We retrospectively analyzed the data from 655 patients with lung metastases from RCC, who were treated at Moscow city oncology Hospital No. 62 (Moscow) and city clinical oncology center (Saint Petersburg) from 2006 to 2022. Of these patients, 241 (36.8 %) were classified into the intermediate prognosis group, and 278 (42.2 %) into the unfavorable prognosis group. The study investigated clinical and morphologic prognostic factors influencing survival rates in patients with lung metastases from RCC. Statistical analysis was performed using Statistica 10.0 software packages (StatSoft, USA) by constructing Kaplan-Meier curves and survival tables, building a mathematical model of survival. Results . The 3- and 5-year OS rates in patients with lung metastases from RCC (N=655) were 48 % [95 % ci 45–53 %] and 27 % [95 % ci 23–31 %], respectively, with a median OS of 34.9 months [95 % ci 30.4–37.4]. in univariate analysis, ECOG status (p

AB - In patients with lung metastases from renal cell cancer (RCC), it is necessary to search for new prognostic factors influencing survival rates. Aim : To analyze survival rates and identify prognostic factors in patients with lung metastases from RCC. Material and methods . We retrospectively analyzed the data from 655 patients with lung metastases from RCC, who were treated at Moscow city oncology Hospital No. 62 (Moscow) and city clinical oncology center (Saint Petersburg) from 2006 to 2022. Of these patients, 241 (36.8 %) were classified into the intermediate prognosis group, and 278 (42.2 %) into the unfavorable prognosis group. The study investigated clinical and morphologic prognostic factors influencing survival rates in patients with lung metastases from RCC. Statistical analysis was performed using Statistica 10.0 software packages (StatSoft, USA) by constructing Kaplan-Meier curves and survival tables, building a mathematical model of survival. Results . The 3- and 5-year OS rates in patients with lung metastases from RCC (N=655) were 48 % [95 % ci 45–53 %] and 27 % [95 % ci 23–31 %], respectively, with a median OS of 34.9 months [95 % ci 30.4–37.4]. in univariate analysis, ECOG status (p

UR - https://www.mendeley.com/catalogue/1e33ec09-eee6-3e92-89d5-f5bc3b8ac6bd/

U2 - 10.21294/1814-4861-2024-23-2-37-46

DO - 10.21294/1814-4861-2024-23-2-37-46

M3 - статья

VL - 23

SP - 37

EP - 46

JO - СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ

JF - СИБИРСКИЙ ОНКОЛОГИЧЕСКИЙ ЖУРНАЛ

SN - 1814-4861

IS - 2

ER -

ID: 119816508